Wintrust Investments’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$2.24M Sell
4,298
-201
-4% -$105K 1.97% 13
2024
Q3
$2.21M Sell
4,499
-41,462
-90% -$19.3M 1.64% 14
2024
Q2
$20.4M Buy
45,961
+5,669
+14% +$2.26M 1.66% 14
2024
Q1
$16.1M Buy
40,292
+1,696
+4% +$641K 1.42% 12
2023
Q4
$13M Buy
38,596
+2,682
+7% +$799K 1.26% 13
2023
Q3
$10.5M Sell
35,914
-9,614
-21% -$3M 1.1% 16
2023
Q2
$15.6M Buy
45,528
+5,915
+15% +$1.79M 1.56% 12
2023
Q1
$10.1M Buy
+39,613
New +$9.76M 1.29% 14
2022
Q4
Sell
-22,955
Closed -$4.3M 389
2022
Q3
$4.3M Buy
22,955
+11,000
+92% +$2.36M 0.54% 39
2022
Q2
$2.4M Sell
11,955
-31,180
-72% -$7.31M 0.29% 60
2022
Q1
$13M Sell
43,135
-6,959
-14% -$2.03M 1.25% 14
2021
Q4
$18M Buy
50,094
+29,673
+145% +$10.2M 1.71% 12
2021
Q3
$6.77M Buy
+20,421
New +$6.86M 0.91% 21

Other funds holding ISRG

Wintrust Investments's ISRG Position: Q4 2024 in Review

Wintrust Investments reduced its Intuitive Surgical (ISRG) stake by 4.5% in Q4 2024, selling an estimated $105K and leaving 4,298 shares worth $2.24M. The position accounts for 1.97% of the portfolio, ranked #13.

Wintrust Investments first reported a position in ISRG in Q3 2021 and has held it in 13 quarters since. The position peaked at $20.4M in Q2 2024. 2,135 funds tracked by Wall St. Rank hold ISRG as of Q4 2024.

  • Wintrust Investments held 4,298 shares of Intuitive Surgical worth $2.24M as of Q4 2024.
  • Wintrust Investments sold 201 Intuitive Surgical shares in Q4 2024, an estimated $105K.
  • Intuitive Surgical made up 1.97% of Wintrust Investments's portfolio in Q4 2024, its #13 holding.
  • Wintrust Investments first reported a position in Intuitive Surgical in Q3 2021 and has held it in 13 quarters since.
  • Wintrust Investments's Intuitive Surgical position peaked at $20.4M in Q2 2024.
  • 2,135 funds tracked by Wall St. Rank held Intuitive Surgical as of Q4 2024.

Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.